|
Study Highlights The Role of Folic Acid In Reducing Neural Tube Defects
 |
"The biggest way you can measure this is in human terms. We're talking
about the difference between a child not making it at all and a child who may
grow up to be an Olympic athlete. "
— Robert Best, Ph.D. |
Before Michelle Weeks gave birth to a baby girl with spina bifida in 1995,
she had never even heard of the birth defect. “We didn’t know in
advance, so it was terrifying for us,”
said the Fort Mill, South Carolina resident. “My mom went
to the library the next day to find out as much as possible,”
she recalled.
While Weeks’ daughter, Brittany, had surgery on her spine when she was
less than 24 hours old, the little girl has not required any additional operations
and is now a healthy, active seven-year-old. Weeks and her husband learned just
how devastating spina bifida can be, and how fortunate Brittany is not to suffer
serious problems such as muscle paralysis and loss of bowel and bladder control.
That’s why the couple was more than willing to get involved with a long-term
research study being conducted by the Division of Genetics. A joint effort with
the Medical University of South Carolina and the Greenwood Genetic Center, the
project was launched 12 years ago to study the effectiveness of folic acid supplements
in women who previously had a baby with a neural tube defect. “I wanted
to help with the study so that other women would know what precautions to take
to help prevent defects,” Weeks said.
Weeks is one of 370 women involved in the project who had a prior pregnancy
with a neural tube defect such as spina bifida or anencephaly. Women from throughout
the state are invited to participate after being identified as being appropriate
for inclusion in the study.
“We find them by every means imaginable, from ultrasound
diagnosis to live birth and fetal death records,” said Robert Best, Ph.D.,
Director, Division of Genetics. The Division of Genetics also studies a control
group of women who have not experienced neural tube defects.
Once women are enrolled in the study, they meet with a genetic counselor.
Through a comprehensive series of written questions and a face-to-face interview,
the counselor obtains a profile on each woman, from what she ate during her previous
pregnancy to where she worked to a detailed family medical history. “The
whole point is to gather information on what these pregnancies with neural tube
defects have in common,” said Carolyn Lovell, one of the prenatal genetic
counselors who works with the participants and the project coordinator for the
Division of Genetics.
Education on folic acid and the role it plays in the early stages of pregnancy
is a critical component of the study. "Ideally women would get adequate
folic acid nutritionally. The practical fact of the matter is that getting people
to eat healthy, balanced diets every day is difficult," said Dr. Best. So
participants are advised to take a daily multivitamin with 400 micrograms of
folic acid. The genetic counselors stay in contact with the women by phone, calling
them at least every three months to check on them and address any questions and
concerns they may have.
If a woman relates that she is considering another pregnancy, then a ten times
higher dose of folic acid is prescribed (4 milligrams), which needs to be taken
at least three months before conception and in early pregnancy. Over the 12-year
period, the outcomes of 276 subsequent pregnancies were documented. Only two
women had recurrences of neural tube defects, neither of whom took folic acid. "We
would have expected 10 or so babies with neural tube defects with this number
of subsequent pregnancies. Approximately half of them would have passed away
prior to birth due to life-threatening birth defects, and the other five would
have had potentially serious problems with their spinal cord, " said Dr.
Best. "This long term prospective study confirms what we suspected about
the importance of prevention through folic acid," he said.
The study will continue as long as funding remains available. Dr. Best credits
Dr. Roger Stephenson for his leadership role in developing the statewide project
and in securing financial support year after year. "We would like to expand
the study to evaluate other types of birth defects and how they might respond
to vitamins,"
he said.
Dr. Best is encouraged by the work that has been done to date.
"The biggest way you can measure this is in human terms. We're
talking about the difference between a child not making it at all and a child
who may grow up to become an Olympic athlete. There are 10 children walking around
in South Carolina today because they got past that critical stage of development
in the first month after conception," he said.
Reprinted from Connections newsletter, July 2002
Connections is produced twice a year by University Specialty Clinics. Connections articles
are copyrighted and may be download and/or reprinted for personal use only. Prior
written consent is required in order to reprint or electronically reproduce any
articles, graphics, and photographs appearing on the website. For more information,
contact Diane J. Epperly, Connections editor, at wordchef@atlanticbb.net .
|